AGENDA
Virtual media briefing
18:00 - 19:30 CEST
12:00 - 13:30 EST
Thursday, September 10, 2020
|
SESSION TITLE |
SPEAKERS |
|
Opening and welcome |
Dr. Kirhan Ozgurdal, Global Medical Affairs Physician – Oncology, Bayer |
|
Importance of improving survival in patients with unresectable HCC |
Dr. Catherine Frenette, Scripps Green Hospital, USA |
|
Changing treatment landscape and importance of systemic therapy sequencing |
Prof. Peter Galle, University Medical Center Mainz, Germany |
|
Effective treatment and management plan to improve survival in HCC |
Dr. Richard Finn, UCLA Medical Center, USA |
|
Facilitated Q&A |
Dr. Catherine Frenette, Prof. Richard Finn, Prof. Peter Galle, Prof. Jean-Frédéric Blanc, Le Centre Hospitalier Universitaire de Bordeaux, France |
|
Summary and close |
Dr. Catherine Frenette |
|
Opportunity for 1:1 interviews with panellists |
Dr. Catherine Frenette and Dr. Richard Finn, USA Prof. Peter Galle, Germany, Prof. Jean-Frédéric Blanc, France |